Annual report pursuant to Section 13 and 15(d)

Note 2 - Shareholders' Equity - Option Transaction Summary (Details)

v3.20.2
Note 2 - Shareholders' Equity - Option Transaction Summary (Details) - $ / shares
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Options, outstanding (in shares) 290,750 138,500
Weighted-average exercise price, outstanding (in dollars per share) $ 11.86 $ 10.99
Granted (in shares) 121,350 172,000
Weighted-average exercise price, Granted (in dollars per share) $ 12.43 $ 12.17
Weighted-average fair value, Granted (in dollars per share) $ 4.62 $ 3.53
Cancelled or Forfeited (in shares) (48,250) (12,000)
Weighted-average exercise price, Cancelled or Forfeited (in dollars per share) $ 13.35 $ 12.17
Exercised (in shares) (26,750) (7,750)
Weighted-average exercise price, Exercised (in dollars per share) $ 4.01 $ 2.58
Options, outstanding (in shares) 337,100 290,750
Weighted-average exercise price, outstanding (in dollars per share) $ 12.48 $ 11.86